Clinical Trial Update: Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO)

View source ↗

Summary

The PEAR-GLIO trial evaluating an AI R&D tool for adult gliomas and other primary brain tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ependymoma
• Glioblastoma
• Glioma
• Oligodendroglioma

Snippet

Sponsor: Ourotech, Inc. | Conditions: Brain Tumor, Glioma, Malignant | Status: TERMINATED